Clin Endosc.  2024 May;57(3):350-363. 10.5946/ce.2023.144.

Endoscopic resection of gastric gastrointestinal stromal tumor using clip-and-cut endoscopic full-thickness resection: a single-center, retrospective cohort in Korea

Affiliations
  • 1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 2Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
  • 3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Abstract

Background/Aims
To overcome the technical limitations of classic endoscopic resection for gastric gastrointestinal stromal tumors (GISTs), various methods have been developed. In this study, we examined the role and feasibility of clip-and-cut procedures (clip-and-cut endoscopic full-thickness resection [cc-EFTR]) for gastric GISTs.
Methods
Medical records of 83 patients diagnosed with GISTs after endoscopic resection between 2005 and 2021 were retrospectively reviewed. Moreover, clinical characteristics and outcomes were analyzed.
Results
Endoscopic submucosal dissection (ESD) and cc-EFTR were performed in 51 and 32 patients, respectively. The GISTs were detected in the upper third of the stomach for ESD (52.9%) and cc-EFTR (90.6%). Within the cc-EFTR group, a majority of GISTs were located in the deep muscularis propria or serosal layer, accounting for 96.9%, as opposed to those in the ESD group (45.1%). The R0 resection rates were 51.0% and 84.4% in the ESD and cc-EFTR groups, respectively. Seven (8.4%) patients required surgical treatment (six patients underwent ESD and one underwent cc-EFTR,) due to residual tumor (n=5) and post-procedure adverse events (n=2). Patients undergoing R0 or R1 resection did not experience recurrence during a median 14-month follow-up period, except for one patient in the ESD group.
Conclusions
cc-EFTR displayed a high R0 resection rate; therefore, it is a safe and effective therapeutic option for small gastric GISTs.

Keyword

Endoscopic full-thickness resection; Endoscopic submucosal dissection; Esophagogastroduodenoscopy; Gastrointestinal stromal tumors; Surgical endoscopy

Figure

  • Fig. 1. Flowchart of patient inclusion. SET, subepithelial tumor; ER, endoscopic resection; GIST, gastrointestinal stromal tumor; NIH, National Institute of Health; STER, submucosal tunneling endoscopic resection; EUS, endoscopic ultrasonography; ESD, endoscopic submucosal dissection; cc-EFTR, clip-and-cut endoscopic full-thickness resection.

  • Fig. 2. (A–H) Case illustration of endoscopic submucosal dissection. (A) A subepithelial tumor (SET) in the distal antrum. (B) After marking around the lesion with an endoscopic knife, submucosal injection is administered. (C–F) Circumferential incision followed by submucosal dissection is performed. (G) After removing the SET, hemostasis is performed with coagulation forceps. (H) The removed gastric SET is displayed. (I–P) Case illustration of clip-and-cut endoscopic full-thickness resection. (I) A SET in the fundus is displayed. (J) Submucosal injection and circumferential incision are performed. (K) A clip with dental floss is applied to the mucosa above the SET for traction. (L) Sentinel clips are placed on both sides of the resected area to anchor the muscularis propria layer. (M) Transmural resection is performed using continuous traction to pull the SET into the stomach. (N) Transmural resection and perforation closure with clips are carried out simultaneously. (O) After the SET is completely excised, additional clipping is performed to strengthen the closure site. (P) The removed gastric SET is displayed.

  • Fig. 3. Differences between the resection margin status and procedure time according to location. To investigate the efficacy of endoscopic submucosal dissection (ESD) and clip-and-cut endoscopic full-thickness resection (cc-EFTR) according to location, the state of resection margin and procedure time are compared between the upper third and middle plus lower third groups. Unlike the middle plus lower third group, which had no differences in resection margin and procedure time, the R0 resection rate is significantly high in cc-EFTR in the upper third groups. (A, B) Resection margin status of upper third and middle plus lower third. (C, D) Procedure time of upper third and middle plus lower third.

  • Fig. 4. Clinical outcomes of the endoscopic resection methods. Summary of each treatment’s oncologic follow-up. ESD, endoscopic submucosal dissection; cc-EFTR, clip-and-cut endoscopic full-thickness resection.


Cited by  1 articles

Endoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges
Jin Woong Cho
Clin Endosc. 2024;57(3):329-331.    doi: 10.5946/ce.2024.036.


Reference

1. Deprez PH, Moons LM, OʼToole D, et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2022; 54:412–429.
Article
2. Lu J, Lu X, Jiao T, et al. Endoscopic management of upper gastrointestinal submucosal tumors arising from muscularis propria. J Clin Gastroenterol. 2014; 48:667–673.
Article
3. Cho JW; Korean ESD Study Group. Current guidelines in the management of upper gastrointestinal subepithelial tumors. Clin Endosc. 2016; 49:235–240.
Article
4. Yang Z, Gao Y, Fan X, et al. A multivariate prediction model for high malignancy potential gastric GI stromal tumors before endoscopic resection. Gastrointest Endosc. 2020; 91:813–822.
Article
5. Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019; 10:144–154.
Article
6. Ko WJ, Cho JY. Current techniques for treating gastrointestinal stromal tumors in the upper gastrointestinal tract. Clin Endosc. 2016; 49:226–228.
Article
7. Schmieder M, Henne-Bruns D, Mayer B, et al. Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection. Front Pharmacol. 2016; 7:504.
Article
8. Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010; 8 Suppl 2(0 2):S1–S41.
Article
9. Kim GH, Choi KD, Gong CS, et al. Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case-control study. Gastrointest Endosc. 2020; 91:527–536.
Article
10. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008; 39:1411–1419.
Article
11. Chak A, Canto MI, Rösch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997; 45:468–473.
Article
12. Palazzo L, Landi B, Cellier C, et al. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut. 2000; 46:88–92.
Article
13. Joo MK, Park JJ, Kim H, et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract. Gastrointest Endosc. 2016; 83:318–326.
Article
14. McCarter MD, Antonescu CR, Ballman KV, et al. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg. 2012; 215:53–60.
Article
15. Zhu Y, Xu MD, Xu C, et al. Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin. Surg Endosc. 2020; 34:159–169.
Article
16. Chapman BC, McIntosh KE, Jones EL, et al. Postoperative pneumoperitoneum: is it normal or pathologic? J Surg Res. 2015; 197:107–111.
Article
17. Li QL, Yao LQ, Zhou PH, et al. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a large study of endoscopic submucosal dissection (with video). Gastrointest Endosc. 2012; 75:1153–1158.
Article
18. An W, Sun PB, Gao J, et al. Endoscopic submucosal dissection for gastric gastrointestinal stromal tumors: a retrospective cohort study. Surg Endosc. 2017; 31:4522–4531.
Article
19. Białek A, Wiechowska-Kozłowska A, Pertkiewicz J, et al. Endoscopic submucosal dissection for treatment of gastric subepithelial tumors (with video). Gastrointest Endosc. 2012; 75:276–286.
Article
20. Tan Y, Tan L, Lu J, et al. Endoscopic resection of gastric gastrointestinal stromal tumors. Transl Gastroenterol Hepatol. 2017; 2:115.
Article
21. Huberty V, Verset L, Deviere J. Endoscopic full-thickness resection of a gastric GI stromal tumor. VideoGIE. 2019; 4:120–122.
Article
22. Guo JT, Zhang JJ, Wu YF, et al. Endoscopic full-thickness resection using an over-the-scope device: a prospective study. World J Gastroenterol. 2021; 27:725–736.
Article
23. Schlag C, Wilhelm D, von Delius S, et al. EndoResect study: endoscopic full-thickness resection of gastric subepithelial tumors. Endoscopy. 2013; 45:4–11.
Article
24. Meier B, Schmidt A, Glaser N, et al. Endoscopic full-thickness resection of gastric subepithelial tumors with the gFTRD-system: a prospective pilot study (RESET trial). Surg Endosc. 2020; 34:853–860.
Article
25. Schmidt A, Bauder M, Riecken B, et al. Endoscopic full-thickness resection of gastric subepithelial tumors: a single-center series. Endoscopy. 2015; 47:154–158.
Article
26. Inoue H, Ikeda H, Hosoya T, et al. Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia. Endoscopy. 2012; 44:225–230.
Article
27. Lv XH, Wang CH, Xie Y. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors: a systematic review and meta-analysis. Surg Endosc. 2017; 31:49–63.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr